Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer

These findings suggest integration of genomic and clinicopathologic risk may lead to more nuanced risk assessment in prostate cancer and may help individualize treatment consideration.

Authors

Institutions

Publication Details

Journal
Prostate Cancer and Prostatic Diseases
Published
2025-12-09
DOI
https://doi.org/10.1038/s41391-025-01062-8
Citations
1
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer

Elai Davicioni, Fábio Ynoe de Moraes, Todd Matthew Morgan, Elizabeth C. Chase et al.
1 citations
Prostate Cancer and Prostatic Diseases
Prostate Cancer Diagnosis and Treatment
1.52
article

Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer

Elai Davicioni, Fábio Ynoe de Moraes, Todd Matthew Morgan, Elizabeth C. Chase, Krithika Suresh, Robert Timothy Dess, Stephen J. Freedland, Angela Y. Jia, Brian J. Davis, Brad J. Stish, William J. Aronson, Curtiland Deville, Ralph Jiang, Matthew J. Schipper, Udit Singhal, Will Jackson, Daniel Eidelberg Spratt, Martha K. Terris, Michael J. Zeléfsky, Soumyajit Roy, Matthew R. Cooperberg, Alejandro Berlín, Tudor Borza, James A. Proudfoot, R. Jeffrey Karnes, Jonathan Shoag, Nicholas G. Zaorsky
article en
1 citations

Abstract

These findings suggest integration of genomic and clinicopathologic risk may lead to more nuanced risk assessment in prostate cancer and may help individualize treatment consideration.

Prostate Cancer and Prostatic Diseases
Cedars-Sinai Medical Center (US), Johns Hopkins University (US), University of Toronto (CA), Queen's University (CA), Augusta University (US), University of Michigan (US), Johns Hopkins Medicine (US), Kingston General Hospital (CA), Los Angeles Medical Center (US), University of California San Francisco Medical Center (US), Michigan Medicine (US), University Hospitals Seidman Cancer Center (US), Veracyte (United States) (US), Mayo Clinic in Arizona (US), Durham VA Medical Center (US), New York University (US)
Prostate Cancer Foundation, A. Alfred Taubman Medical Research Institute, National Institutes of Health
Openalex Percentile: Top 12%
Prostate Cancer Diagnosis and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.